RFTECH's Collateral for Subsidiary RFBio Ends Early Due to Debt Repayment, Management Transfer Delayed

RFTECH's collateral provision for its subsidiary RFBio's borrowings of 15 billion KRW was terminated early on April 16, 2026, due to debt repayment. The collateral amount was approximately 11.2 billion KRW, representing 6.01% of RFTECH's equity.
The collateral consisted of 910,747 registered common shares of RFBio, which are intended to be transferred under a management rights acquisition agreement, making the collateral temporary.
RFBio's financials as of end-2025 show total assets of 106.9 billion KRW, total liabilities of 65.6 billion KRW, and a net loss of 7.4 billion KRW, indicating weak financial health. RFTECH has outstanding loans to this subsidiary.
[AI Summary]The termination of collateral is a normal event due to debt repayment, causing no direct shareholder dilution. However, the delay in the subsidiary's management transfer and its fragile financial position introduce short-term uncertainty. The impact on stock price is limited, but investors should monitor progress.